A patient receives a shot in the first-stage safety study of Moderna's potential vaccine Source: AAP
A second experimental coronavirus vaccine is showing promising results with late-stage clinical trials of Moderna’s main candidate appearing to be almost 95 per cent effective.
A second experimental coronavirus vaccine is showing promising results with late-stage clinical trials of Moderna’s main candidate appearing to be almost 95 per cent effective.
Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.
